Peer-reviewed veterinary case report
Travoprost vs latanoprost eye pressure effects in normal dogs
By Carvalho, Alex B et al.·Published in Veterinary ophthalmology·2006·Department of Surgery, Brazil·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Effects of travoprost 0.004% compared with latanoprost 0.005% on the intraocular pressure of normal dogs.
- Species:
- dog
Plain-English summary
A group of mixed breed dogs had their eye pressure measured to see how two different eye drops, travoprost and latanoprost, affected it. Both medications were found to lower eye pressure effectively, with no significant difference between the two. Some dogs experienced mild side effects like constricted pupils and redness in the eyes, but overall, both treatments worked well. This study suggests that travoprost is a good option for managing eye pressure in dogs, similar to latanoprost.
People also search for: dog eye pressure treatment · travoprost for dogs · latanoprost side effects in dogs
Abstract
PURPOSE: To compare the effects of travoprost 0.004% and latanoprost 0.005% on the intraocular pressure (IOP) of normal dogs. METHODS: Twenty mixed breed dogs were randomized to two groups: latanoprost was used in group A and travoprost in group B. The drugs were instilled in the right eye of the dogs, whereas the left eye received placebo. Both drugs were instilled once a day at 8 am during 5 days. IOP measurements were made at 8 am, 10 am, 2 pm and 8 pm during the 5 days of treatment, the 3 days that preceded treatment, and 3 days following treatment. Presence of blepharospasm, miosis, anterior chamber flare, and conjunctival hyperemia were evaluated during the study. RESULTS: Mean IOP was significantly reduced in the eyes treated with both latanoprost and travoprost, when compared with the eyes treated with placebo (P<0.05). There was no statistically significant difference between the mean IOPs of eyes treated with latanoprost and travoprost at all time intervals during baseline, treatment, and recovery (P>0.05). On the fifth day of treatment and on the first day of the recovery period, a severe ocular hypotension was noted with both drugs, resulting in imprecise readings with the tonometer. Miosis and conjunctival hyperemia were observed in the treated eyes of both groups, whereas flare was noticed in one latanoprost-treated eye. CONCLUSION: Travoprost 0.004% significantly reduces the IOP in normal dogs. The hypotensive effect obtained with travoprost 0.004% is comparable to that obtained with latanoprost 0.005%.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/16497237/